Nanofilm Technologies (MZH) investor relations material

Executive summary

• 1H2026 revenue rose 6.1% YoY to S$113.7m; gross margin reached 38.6%, Adjusted EBITDA increased 28.1% to S$31.3m, and profit after tax rose 282% to S$5.3m.

• Growth was led by AMBU and NFBU, while IEBU and Sydrogen declined; a healthy IEBU backlog supports stronger 2H2026 deliveries and visibility into 2027.

Financial highlights

• Revenue was S$113.7m, up 6.1% YoY from S$107.2m; gross profit increased 25.5% to S$43.8m.

• Basic and diluted EPS rose to 0.65 cents from 0.25 cents; cash and cash equivalents were S$88.7m at period end.

• Net asset value per share improved to 68.52 cents from 67.11 cents at year-end 2025.

Outlook and guidance

• Core businesses are expected to sustain momentum through new product applications, programme ramp-ups, and new business opportunities.

• IEBU’s healthy order backlog supports stronger 2H2026 deliveries, with revenue visibility extending into 2027.

• AMBU Consumer growth is expected from programme ramp-ups, functional coatings including conductive ta-C, and engagement with Chinese and Korean customers.

• Sydrogen is progressing commercialisation and targeting microgrids, data centres, and off-grid applications; it aims for EBITDA positivity by year-end.

• New product lines and equipment solutions are progressing toward commercialisation, with expansion focused on China and the global footprint.